{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:54:22Z","timestamp":1776092062283,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.psychres.2022.114620","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T23:15:39Z","timestamp":1652138139000},"page":"114620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Alopecia associated with the use of selective serotonin reuptake inhibitors: Systematic review"],"prefix":"10.1016","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1741-0025","authenticated-orcid":false,"given":"Ana V.","family":"Pejcic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2022.114620_bib0001","series-title":"Alopecia, in\u2013StatPearls","author":"Al Aboud","year":"2021"},{"key":"10.1016\/j.psychres.2022.114620_bib13","first-page":"e4000","article-title":"Hair loss associated with sertraline: Two case reports and review","volume":"11","author":"Elyasi","year":"2017","journal-title":"Iran. J. Psychiatry Behav. Sci."},{"key":"10.1016\/j.psychres.2022.114620_bib0002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/YIC.0000000000000191","article-title":"Risk of hair loss with different antidepressants\u2013A comparative retrospective cohort study","volume":"33","author":"Etminan","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114620_bib0003","unstructured":"Food and Drug Administration, 2022. Drugs@FDA: FDA-Approved Drugs. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm (accessed 25 April 2022)."},{"key":"10.1016\/j.psychres.2022.114620_bib0004","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1345\/aph.18346","article-title":"Alopecia due to psychotropic medications","volume":"33","author":"Gautam","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.psychres.2022.114620_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2019.02.063","article-title":"Plasma serotonin levels are associated with antidepressant response to SSRIs","volume":"250","author":"Holck","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2022.114620_bib0006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-4632.2004.01834.x","article-title":"Serotonin in alopecia areata\u2013An enzyme immunoassay study","volume":"43","author":"Huang","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.psychres.2022.114620_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00002018-200730050-00001","article-title":"Guidelines for submitting adverse event reports for publication","volume":"30","author":"Kelly","year":"2007","journal-title":"Drug. Saf."},{"key":"10.1016\/j.psychres.2022.114620_bib0008","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5350\/DAJPN2016290108","article-title":"Alleviation of alopecia after switching from escitalopram to duloxetine\u2013A case report","volume":"29","author":"Kocbiyik","year":"2016","journal-title":"Dusunen Adam J. Psychiatry Neurol. Sci."},{"key":"10.1016\/j.psychres.2022.114620_bib0009","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaad.2006.10.020","article-title":"Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors","volume":"56","author":"Krasowska","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.psychres.2022.114620_bib0010","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement\u2013An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2022.114620_bib0011","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1096\/fj.04-2079rev","article-title":"The cutaneous serotoninergic\/melatoninergic system\u2013Securing a place under the sun","volume":"19","author":"Slominski","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.psychres.2022.114620_bib0012","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/WNF.0000000000000205","article-title":"Increased trichotillomania symptoms in a child with fluoxetine treatment","volume":"40","author":"Yekta\u015f","year":"2017","journal-title":"Clin. Neuropharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122002219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122002219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:54:57Z","timestamp":1759038897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122002219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":13,"alternative-id":["S0165178122002219"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114620","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia associated with the use of selective serotonin reuptake inhibitors: Systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114620"}}